MARKET

KRBPQ

KRBPQ

Kiromic Biopharma Inc
EXMKT
0.0003
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.0050
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
20.10
52 WEEK LOW
0.0003
MARKET CAP
459.98
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KRBPQ last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at KRBPQ last week (1117-1121)?
Weekly Report · 11/24 10:13
Weekly Report: what happened at KRBPQ last week (1110-1114)?
Weekly Report · 11/17 10:13
Weekly Report: what happened at KRBPQ last week (1103-1107)?
Weekly Report · 11/10 10:11
Weekly Report: what happened at KRBPQ last week (1027-1031)?
Weekly Report · 11/03 10:11
Kiromic Biopharma’s Innovative Cancer Treatment Study: A Potential Game-Changer
TipRanks · 10/27 17:26
Weekly Report: what happened at KRBPQ last week (1020-1024)?
Weekly Report · 10/27 10:14
Weekly Report: what happened at KRBPQ last week (1013-1017)?
Weekly Report · 10/20 10:11
More
About KRBPQ
Kiromic BioPharma, Inc. is a clinical-stage, fully integrated biotherapeutics company. The Company is engaged in developing an allogeneic Gamma Delta T-cell therapy featuring proprietary end-to-end bioinformatic, artificial intelligence (AI) targeting and manufacturing technologies to address solid tumors. It has five clinical programs to study its key product candidates: Deltacel-01, Alexis-ISO-1, Alexis-PRO-1, Isocel combination, and Procel combination. Deltacel is its first allogeneic, off-the-shelf GDT cell-based product in Phase I clinical-stage. Its Procel and Isocel product candidates consist of allogeneic, engineered, off-the-shelf GDT cells, and they are in the preclinical development stage. Its Isocel product candidate consists of engineered GDTs that target Mesothelin Isoform 2, a target that has been discovered and prioritized using its Diamond AI bio-informatic platform. Its Procel product candidate consists of engineered GDTs that target PD-L1.

Webull offers Kiromic Biopharma Inc stock information, including EXMKT: KRBPQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRBPQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRBPQ stock methods without spending real money on the virtual paper trading platform.